Literature DB >> 28838410

The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.

Sahil Khanna1, Laura E Raffals2.   

Abstract

Individuals with a genetic predisposition to Crohn's disease develop aberrant immune responses to environmental triggers. The gastrointestinal microbiota is increasingly recognized to play an important role in the development of Crohn's disease. Decrease in global gut microbial diversity and specific bacterial alterations have been implicated in Crohn's disease. Advances in sequencing techniques and bioinformatics and correlation with host genetics continue to improve insight into the structure and function of the microbial community and interactions with the host immune system. This article summarizes the existing literature on the role of the gut microbiome and its manipulation in the development and management of Crohn's disease.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crohn's disease; Fecal microbiota transplantation; Gut microbiota; Inflammatory bowel disease; Microbiome; Pathogenesis; Probiotics

Mesh:

Year:  2017        PMID: 28838410     DOI: 10.1016/j.gtc.2017.05.004

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  21 in total

Review 1.  Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.

Authors:  Jin Ah Cho; Daniel J F Chinnapen
Journal:  J Microbiol       Date:  2018-02-28       Impact factor: 3.422

Review 2.  Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.

Authors:  Reem Rashed; Rosica Valcheva; Levinus A Dieleman
Journal:  Front Med (Lausanne)       Date:  2022-06-16

Review 3.  Role of Diet in the Development and Management of Crohn's Disease.

Authors:  Donald Goens; Dejan Micic
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

4.  AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders.

Authors:  Geoffrey A Preidis; Adam V Weizman; Purna C Kashyap; Rebecca L Morgan
Journal:  Gastroenterology       Date:  2020-06-09       Impact factor: 22.682

5.  Immunologic Complications and Graft Survival in Crohn's Disease and NOD2 Mutant Non-Crohn's Disease Adult Recipients Following Intestine Transplantation.

Authors:  Leonid Belyayev; Jason Hawksworth; Khalid Khan; Stuart Kaufman; Sukanya Subramanian; Alexander Kroemer; Katrina Loh; Raffaele Girlanda; Thomas M Fishbein; Cal S Matsumoto
Journal:  Transplant Direct       Date:  2020-05-21

6.  Thalidomide Prevented and Ameliorated Pathogenesis of Crohn's Disease in Mice via Regulation of Inflammatory Response and Fibrosis.

Authors:  Hongjin Chen; Haixia Xu; Lijiao Luo; Lichao Qiao; Yaohui Wang; Minmin Xu; Youran Li; Ping Zhu; Bolin Yang
Journal:  Front Pharmacol       Date:  2019-12-13       Impact factor: 5.810

7.  Development of Allergic Bronchopulmonary Aspergillosis in a Patient with Crohn's Disease.

Authors:  Hisashi Sasaki; Jun Miyata; Yohei Maki; Yoshifumi Kimizuka; Nobuyoshi Hayashi; Yuji Fujikura; Akihiko Kawana
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

8.  The ecogenomics of dsDNA bacteriophages in feces of stabled and feral horses.

Authors:  V V Babenko; A Millard; E E Kulikov; N N Spasskaya; M A Letarova; D N Konanov; I S Belalov; A V Letarov
Journal:  Comput Struct Biotechnol J       Date:  2020-11-10       Impact factor: 7.271

Review 9.  Management of Crohn Disease: A Review.

Authors:  Kelly Cushing; Peter D R Higgins
Journal:  JAMA       Date:  2021-01-05       Impact factor: 157.335

Review 10.  Therapies to modulate gut microbiota: Past, present and future.

Authors:  Akshita Gupta; Srishti Saha; Sahil Khanna
Journal:  World J Gastroenterol       Date:  2020-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.